Although we also observed that plasma GSH and GSSG levels were both lowered in our CRC patients after chemotherapy compared to non-chemotherapy patients, their plasma GPx and GR levels in response to chemotherapy were increased instead of decreased. This evidence concerns the gene GSR and colorectal carcinoma.